Lisata Therapeutics Inc (LTS:0HS8) Stock News, Headlines & Updates
Lisata Therapeutics Inc Stock News from GuruFocus
- 1
Aug 13, 2024
Lisata Therapeutics Inc (LSTA) Q2 2024 Earnings Call Transcript Highlights: Significant Expense Reductions and Strong Cash Position
GuruFocus Research • 3:01am
Q2 2024 Lisata Therapeutics Inc Earnings Call Transcript
GuruFocus Research • 2:02am
Aug 12, 2024
Lisata Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
Marketwired • 4:00pm
Aug 05, 2024
Lisata Therapeutics to Report Second Quarter 2024 Financial Results and Provide a Business Update on Monday, August 12, 2024
Marketwired • 7:00am
Jul 18, 2024
Haystack Oncology and Lisata Therapeutics Initiate Research Collaboration to Use the Haystack MRD™ Technology to Evaluate Efficacy of Pancreatic Cancer Therapy
Marketwired • 7:00am
Jul 16, 2024
Lisata Therapeutics Announces Completion of Enrollment in its Phase 2a BOLSTER Trial of Certepetide in First-Line Cholangiocarcinoma
Marketwired • 7:00am
Jul 10, 2024
Lisata Therapeutics' Certepetide Shows Promise in Improving Standard Treatment for Intrahepatic Cholangiocarcinoma in a Preclinical Model
Marketwired • 7:00am
Jun 13, 2024
Lisata Therapeutics Announces Full Enrollment of Pancreatic Cancer Cohort of CENDIFOX Trial
Marketwired • 8:00am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news